Caplight Directory>Investors>Alwin Capital>Alwin-capital


Alwin Capital

Alwin Capital

Beijing, Beijingalwincapital.com

Overview

Alwin Capital is a venture capital firm in China specializing in early-stage life science investments . Driven by theme-focused research in life science, Alwin Capital has developed investment strategies that capture outstanding opportunities for innovative diagnostic and therapeutic developments . The firm is committed to long-term investment in life science with the pursuit of excess investment return based on scientific insights . Alwin Capital has formed a systematic investment layout covering Innovative Drugs, Molecular Diagnostics, Innovative Hardware, Scientific Services and AI Applications .

Year Founded

2015

AUM

$500M

Portfolio Companies

10

Investments

CompanyDateStageLead
Nanjing Polymer Medical Technology Co., Ltd.Jul 2025Series CCo-investor
Sanegene BioDec 2023Series A ExtensionCo-investor
Shenzhen Institute of Advanced Biomedical Robot Co., Ltd.Jun 2023Series ACo-investor
Sanegene BioAug 2021Series ACo-investor
Abogen BiosciencesAug 2021Series C-
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBeijing, Beijing
Year Founded2015
AUM$500M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.